Lv42
530 积分 2024-04-13 加入
Bispecific antibody drug conjugates: Making 1+1>2
5天前
已完结
GHR signalling: Receptor activation and degradation mechanisms
15天前
已完结
Engineering a bispecific antibody with a common light chain: Identification and optimization of an anti-CD3 epsilon and anti-GPC3 bispecific antibody, ERY974
20天前
已完结
A comprehensive comparison between camelid nanobodies and single chain variable fragments
20天前
已完结
Structural study of a light chain mispaired bispecific predicts mechanism of downstream separation
21天前
已完结
A new approach for generating bispecific antibodies based on a common light chain format and the stable architecture of human immunoglobulin G1
21天前
已完结
Effectiveness of GH therapy in children with normal results of GH stimulation tests and with partial GH deficiency is similar and depends on the severity of IGF1I deficiency
29天前
已完结
Can Machine Learning Overcome the 95% Failure Rate and Reality that Only 30% of Approved Cancer Drugs Meaningfully Extend Patient Survival?
2个月前
已完结
Unlocking the potential of bispecific ADCs for targeted cancer therapy
3个月前
已完结
Mechanism of signaling by growth hormone receptor
3个月前
已关闭
皖公网安备34019202002308
